Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Bioenergetics in diabetic neuropathy: what we need to know.

Hinder LM, Vincent AM, Burant CF, Pennathur S, Feldman EL.

J Peripher Nerv Syst. 2012 May;17 Suppl 2:10-4. doi: 10.1111/j.1529-8027.2012.00389.x. Review.

2.

The role of aberrant mitochondrial bioenergetics in diabetic neuropathy.

Chowdhury SK, Smith DR, Fernyhough P.

Neurobiol Dis. 2013 Mar;51:56-65. doi: 10.1016/j.nbd.2012.03.016. Review.

PMID:
22446165
3.

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

Vincent AM, Callaghan BC, Smith AL, Feldman EL.

Nat Rev Neurol. 2011 Sep 13;7(10):573-83. doi: 10.1038/nrneurol.2011.137. Review.

PMID:
21912405
4.

Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents.

Saleh A, Roy Chowdhury SK, Smith DR, Balakrishnan S, Tessler L, Martens C, Morrow D, Schartner E, Frizzi KE, Calcutt NA, Fernyhough P.

Neuropharmacology. 2013 Feb;65:65-73. doi: 10.1016/j.neuropharm.2012.09.015.

5.
6.

Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental Diabetic Neuropathy.

Freeman OJ, Unwin RD, Dowsey AW, Begley P, Ali S, Hollywood KA, Rustogi N, Petersen RS, Dunn WB, Cooper GJ, Gardiner NJ.

Diabetes. 2016 Jan;65(1):228-38. doi: 10.2337/db15-0835.

7.
8.

Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.

Hinder LM, Vivekanandan-Giri A, McLean LL, Pennathur S, Feldman EL.

J Endocrinol. 2013 Jan 2;216(1):1-11. doi: 10.1530/JOE-12-0356.

9.

How does glucose generate oxidative stress in peripheral nerve?

Obrosova IG.

Int Rev Neurobiol. 2002;50:3-35. Review.

PMID:
12198815
10.

Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.

Stavniichuk R, Shevalye H, Lupachyk S, Obrosov A, Groves JT, Obrosova IG, Yorek MA.

Diabetes Metab Res Rev. 2014 Nov;30(8):669-78. doi: 10.1002/dmrr.2549.

11.

Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.

Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.

Exp Neurol. 2001 Apr;168(2):259-72.

PMID:
11259114
12.
13.

Biology of diabetic neuropathy.

Vincent AM, Calabek B, Roberts L, Feldman EL.

Handb Clin Neurol. 2013;115:591-606. doi: 10.1016/B978-0-444-52902-2.00034-5. Review.

PMID:
23931804
14.

Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events.

Fernyhough P.

Curr Diab Rep. 2015 Nov;15(11):89. doi: 10.1007/s11892-015-0671-9. Review.

PMID:
26370700
15.

Diabetic peripheral neuropathy: current perspective and future directions.

Singh R, Kishore L, Kaur N.

Pharmacol Res. 2014 Feb;80:21-35. doi: 10.1016/j.phrs.2013.12.005. Review.

PMID:
24373831
16.

CHOP/ORP150 ratio in endoplasmic reticulum stress: a new mechanism for diabetic peripheral neuropathy.

Wu YB, Li HQ, Ren MS, Li WT, Lv XY, Wang L.

Cell Physiol Biochem. 2013;32(2):367-79. doi: 10.1159/000354444.

17.

Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.

Yorek MA.

Rev Diabet Stud. 2015 Spring-Summer;12(1-2):13-28. doi: 10.1900/RDS.2015.12.13. Review.

18.
19.

Novel pathogenic pathways in diabetic neuropathy.

Zenker J, Ziegler D, Chrast R.

Trends Neurosci. 2013 Aug;36(8):439-49. doi: 10.1016/j.tins.2013.04.008. Review.

PMID:
23725712
20.

Calcium signalling in sensory neurones and peripheral glia in the context of diabetic neuropathies.

Verkhratsky A, Fernyhough P.

Cell Calcium. 2014 Nov;56(5):362-71. doi: 10.1016/j.ceca.2014.07.005. Review.

PMID:
25149565
Items per page

Supplemental Content

Support Center